Pfizer (NYSE: PFE) EVP amends Form 3 to add plan shares

Rhea-AI Filing Summary

PFIZER INC Executive Vice President Dennis P. Hancock filed an amended Form 3 to correct his initial insider holdings report. The amendment adds 1,940 shares of common stock held indirectly through the Pfizer Savings Plan under a Rule 16b-3 plan that were previously omitted.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hancock Dennis P

Role Executive Vice President

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,940 shares (Indirect, By Rule 16b-3 Plan)

Footnotes (1)

1. [object Object]

Key Figures

Indirectly held common shares: 1,940 shares

1 metrics

Indirectly held common shares 1,940 shares Held in Pfizer Savings Plan under Rule 16b-3 Plan

Key Terms

Form 3/A, Pfizer Savings Plan, Rule 16b-3 Plan

3 terms

Form 3/A regulatory

"This Form 3/A is being filed to include common shares held indirectly"

An amended Form 3 (Form 3/A) is a corrected or updated disclosure filed with regulators that revises an insider’s initial report of their ownership in a public company — typically for officers, directors or large shareholders. Investors use it like a corrected inventory list: it clarifies who owns how many shares and whether earlier reports had errors, helping assess insider confidence, possible conflicts and the accuracy of ownership records that can affect stock valuation and trust.

Pfizer Savings Plan financial

"common shares held indirectly in the Pfizer Savings Plan that were inadvertently omitted"

Rule 16b-3 Plan regulatory

"nature_of_ownership: By Rule 16b-3 Plan"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hancock Dennis P

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026

3. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
04/10/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,940(1)	I	By Rule 16b-3 Plan

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This Form 3/A is being filed to include common shares held indirectly in the Pfizer Savings Plan that were inadvertently omitted from the reporting person's original Form 3 filed on April 10, 2026.

Remarks:

dphxpoa26.htm

	/s/ Shanice A. Reid, by Power of atty, for Dennis P. Hancock	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Pfizer (PFE) Executive Vice President Dennis P. Hancock report in this Form 3/A?

Dennis P. Hancock files an amended Form 3 to correct his initial insider holdings. The amendment reports 1,940 Pfizer common shares held indirectly through the Pfizer Savings Plan that were inadvertently omitted from his original Form 3 filing.

How many Pfizer (PFE) shares does Dennis P. Hancock report indirectly holding?

He reports indirect ownership of 1,940 Pfizer common shares. These shares are held in the Pfizer Savings Plan under a Rule 16b-3 plan structure, and they were previously left out of his original Form 3 insider ownership report.

Why was Dennis P. Hancock’s original Pfizer (PFE) Form 3 amended?

The Form 3 was amended because common shares in the Pfizer Savings Plan were inadvertently omitted. The Form 3/A adds 1,940 indirectly held shares, ensuring his reported insider holdings more accurately reflect participation in the Pfizer Savings Plan.

Are the Pfizer (PFE) shares in this Form 3/A held directly by Dennis P. Hancock?

No, the shares are reported as indirect holdings. The 1,940 Pfizer common shares are held by a Rule 16b-3 Plan within the Pfizer Savings Plan, rather than as directly owned stock in a personal brokerage account.

Does this Pfizer (PFE) Form 3/A show any new insider buying or selling activity?

The amendment does not show new buying or selling transactions. It instead updates existing ownership information, adding 1,940 indirectly held Pfizer common shares in the Pfizer Savings Plan that were omitted from the original Form 3 filing.